. Author manuscript; available in PMC: 2023 Mar 1.

Published in final edited form as: Gastroenterology. 2021 Nov 13;162(3):828–843.e11. doi: 10.1053/j.gastro.2021.11.015

Table 1.

Cohort demographics.

	All (n=1313)			CD (n=464)			UC (n=484)			HC (n=365)
	n	%	median (min-max)	n	%	median (min-max)	n	%	median (min-max)	n	%	median (min-max)
*Age*
at endoscopy	1313	-	46 (18 – 82)	464	-	34 (18 – 78)	484	-	44 (20 – 82)	365	-	54 (20 – 82)
at diagnosis	945	-	25 (2 – 75)	462	-	24 (2 – 69)	483	-	26 (6 – 75)	0	-
*Gender*
Male	680	51.8	-	240	51.7	-	250	51.7	-	190	52.1	-
Female	633	48.2	-	224	48.3	-	234	48.3	-	175	47.9	-
*Metabolomics*
serum stool	973	74.1	-	284	61.2	-	360	74.4	-	329	90.1	-
serum stool	261	19.9	-	88	19	-	101	20.9	-	72	19.7	-
*Genotyping*
genotyping	1251	95.3	-	447	96.3	-	461	95.2	-	343	94	-
*Ancestry*
Asian	16	1.3	-	4	0.9	-	4	0.9	-	8	2.3	-
Black	112	9	-	21	4.7	-	20	4.3	-	71	20.7	-
Mexican	68	5.4	-	21	4.7	-	30	6.5	-	17	5	-
Multiple	114	9.1	-	34	7.6	-	21	4.6	-	59	17.2	-
White	941	75.2	-	367	82.1	-	386	83.7	-	188	54.8	-
*Clinical disease severity*
HBI	464	-	2 (0 – 27)	464	-	2 (0 – 27)	0	-			-
Inactive (0 −4)	352	75.9		352	75.9
Mild (5–7)	67	14.4		67	14.4
Moderate (8–16)	42	9.1		42	9.1
Severe (>16)	3	0.6		3	0.6
SCCAI	484	-	1 (0 – 15)	0	-		484	-	1 (0 – 15)		-
Remission (0–4)	430	88.8					430	88.8
Active (>4)	54	11.1					54	11.1
SESCD	464	-	3 (0 – 41)	464	-	3 (0 – 41)	0	-			-
Inactive(0–2)	198	42.7		194	42.7
Mild (3–6)	133	28.7		133	28.7
Moderate(7–15)	92	19.8		92	19.8
Severe (>15)	41	8.8		41	8.8
Mayo-endo	482	-	1 (0 – 3)	0	-		482	-	1 (0 – 3)		-
Inactive (0)	234	48.5					234	48.5
Mild (1)	153	31.7					153	31.7
Moderate (2)	64	16.3					64	16.3
Severe (3)	31	6.4					31	6.4